Literature DB >> 20881383

Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.

Ann De Smedt1, Sylvie De Raedt, Koenraad Nieboer, Jacques De Keyser, Raf Brouns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20881383     DOI： 10.1159/000319886

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN： 1015-9770            Impact factor:   2.762


× No keyword cloud information.
  14 in total

1.  Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.

Authors:  James Douketis; Alan David Bell; John Eikelboom; Aaron Liew
Journal:  Can Fam Physician       Date:  2014-11       Impact factor: 3.275

2.  Thrombolysis in ischemic stroke patients on treatment with Dabigatran.

Authors:  Giuseppe Re; Danilo Toni
Journal:  Intern Emerg Med       Date:  2013-02-07       Impact factor: 3.397

Review 3.  Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment.

Authors:  Masaki Watanabe; Fazeel M Siddiqui; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

4.  Is intravenous recombinant tissue plasminogen activator (r-tPA) safe in patients on Dabigatran?

Authors:  Raghav Govindarajan; Nestor Galvez
Journal:  J Vasc Interv Neurol       Date:  2014-05

Review 5.  Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Neurohospitalist       Date:  2015-07

6.  Safety of thrombolysis in acute ischemic stroke: a review of complications, risk factors, and newer technologies.

Authors:  Daniel J Miller; Jennifer R Simpson; Brian Silver
Journal:  Neurohospitalist       Date:  2011-07

Review 7.  Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban.

Authors:  T Steiner; M Böhm; M Dichgans; H-C Diener; C Ell; M Endres; C Epple; M Grond; U Laufs; G Nickenig; H Riess; J Röther; P D Schellinger; M Spannagl; R Veltkamp
Journal:  Clin Res Cardiol       Date:  2013-05-14       Impact factor: 5.460

8.  Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats.

Authors:  Zikra Zulfiqar; Fawad Ali Shah; Shagufta Shafique; Abdullah Alattar; Tahir Ali; Arooj Mohsin Alvi; Sajid Rashid; Shupeng Li
Journal:  J Inflamm Res       Date:  2020-12-24

9.  Thrombolysis in a stroke patient on dabigatran anticoagulation: case report and synopsis of published cases.

Authors:  Waltraud Pfeilschifter; Mario Abruscato; Susanne Hövelmann; Horst Baas
Journal:  Case Rep Neurol       Date:  2013-03-25

10.  Dabigatran for stroke prevention in nonvalvular atrial fibrillation: answers to challenging "real-world" questions.

Authors:  Jorge Ferreira; Daniel Ferreira; Miguel Viana-Baptista; Paulo Bettencourt; Rui Cernadas; Francisco Crespo
Journal:  Thrombosis       Date:  2012-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.